Keyphrases
Tumor
81%
Confidence Interval
57%
Neurofibromatosis Type 1 (NF-1)
41%
Breast Cancer
40%
Relative Risk
31%
Breast Cancer Risk
29%
Neurofibromatosis Type I
27%
In Cancer
26%
T Cells
23%
Nurses' Health Study
21%
Hematopoietic Stem Cells
20%
Tumor Cells
18%
Colorectal Cancer
18%
Prostate Cancer
18%
Body Mass Index
18%
Glioblastoma
18%
Overall Survival
17%
Gene Expression
17%
Postmenopausal Women
16%
Radiation Therapy
15%
Risk Factors
15%
Acute Myeloid Leukemia
15%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
15%
Meta-analysis
15%
Odds Ratio
15%
Macrophages
14%
Clinical Trials
14%
Natural Killer Cells
14%
United States
14%
Hazard Ratio
14%
Chemotherapy
14%
Mouse Model
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Bone Marrow
13%
Transcription Factor
13%
Obesity
13%
Apoptosis
13%
Interferon-α (IFN-α)
12%
Physical Activity
12%
Glioma
12%
Cancer Cells
12%
Tumor Growth
11%
Tumor Microenvironment
11%
Osteoclast
11%
Phosphorylation
10%
Clinical Outcomes
10%
Ovarian Cancer
10%
Overexpression
10%
Multiple Myeloma
10%
Tumor Suppressor
10%
Pancreatic Cancer
10%
Brain Tumor
9%
Melanoma
9%
Dendritic Cells
9%
Immune Response
9%
Lung Cancer
9%
Tumorigenesis
9%
Astrocytes
9%
Colorectal Cancer Risk
9%
Optic Pathway Glioma
9%
Malignancy
9%
Estrogen
9%
Coronary Artery Disease
9%
Signaling Pathway
9%
NF-B
8%
High Risk
8%
Granulocyte Colony-stimulating Factor (G-CSF)
8%
Prospective Cohort Study
8%
Inflammation
8%
Metastasis
8%
Ionizing Radiation
8%
Cervical Cancer
8%
Leukemia
8%
Cell Proliferation
8%
Radiotherapy
7%
Human Cancer
7%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
7%
Magnetic Resonance Imaging
7%
Cancer Types
7%
Bladder Cancer
7%
Diabetes
7%
CD8+ T Cells
7%
Cancer Patients
7%
Integrin
7%
Cell Death
7%
Tumor Progression
7%
Systematic Meta-analysis
7%
Oncogene
7%
Virus
7%
Optical Coherence Tomography
7%
Endothelial Cells
7%
DNA Damage
7%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Catenin
7%
Progression-free Survival
7%
Positron Emission Tomography
7%
Colon Cancer
7%
Pancreatic Ductal Adenocarcinoma
6%
Monoclonal Antibody
6%
Non-small Cell Lung Cancer (NSCLC)
6%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
67%
Malignant Neoplasm
60%
Diseases
38%
Neurofibromatosis Type I
28%
Cancer
25%
Radiation Therapy
25%
Ganglioglioma
20%
Colorectal Carcinoma
19%
Metastatic Carcinoma
19%
Prostate Cancer
18%
Cancer Risk
18%
Overall Survival
16%
T Cell
16%
Clinical Trial
15%
Prospective Study
13%
Tumor Progression
13%
Biological Marker
13%
Recurrent Disease
13%
Surgery
12%
Glioblastoma
12%
Cancer Cell
12%
Nurse
12%
Ovarian Cancer
12%
Tumor Cell
12%
In Vitro
12%
Magnetic Resonance Imaging
11%
Hematopoietic Cell
11%
Systematic Review
10%
Body Mass Index
10%
Immunotherapy
10%
Melanoma
10%
Hazard Ratio
10%
Meta-Analysis
10%
Odds Ratio
9%
Positron Emission Tomography
9%
Carcinogenesis
9%
Cancer Therapy
9%
Acute Myeloid Leukemia
8%
Diagnosis
8%
Lung Cancer
8%
Gene Expression
8%
Cervical Cancer
8%
Intracranial Tumor
8%
Diabetes
8%
Receptor
8%
Macrophage
8%
Immunity
8%
Alcohol Consumption
8%
Hematopoiesis
7%
Multiple Myeloma
7%
Programmed Cell Death
7%
Pediatrics
7%
Connective Tissue Cancer
7%
Pancreas Cancer
7%
Protein P53
7%
Optical Coherence Tomography
7%
Physical Activity
7%
Oncology
7%
Targeted Therapy
7%
Tumor Microenvironment
7%
Xenograft
7%
Progression Free Survival
6%
Postmenopause
6%
Osteoclast
6%
Cohort Analysis
6%
Biopsy Technique
6%
Breast Density
6%
Leukemia
6%
Infection
6%
Stem Cell
6%
Bladder Cancer
6%
Immunohistochemistry
6%
Lymph Node
6%
Cell Signaling Pathway
6%
Adolescence
6%
Endothelial Cell
5%
Cancer Mortality
5%
Pancreas Adenocarcinoma
5%
Nanoparticle
5%
Non Small Cell Lung Cancer
5%
Malignant Peripheral Nerve Sheath Tumor
5%
Health Care Cost
5%
Osteolysis
5%
Quality of Life
5%
Isotopes of Calcium
5%
Messenger RNA
5%
Gene Expression Profiling
5%
Adverse Event
5%
Head and Neck Cancer
5%
Gene Mutation
5%
Hormone Therapy
5%
Cardiovascular Disease
5%
Mammography
5%
Uterine Cancer
5%
Prospective Cohort Study
5%